Q97825082

Summary

Q97825082 is an individual motion^[1].

Key Facts

• Q97825082 authored Lars Elinderson^[2].
• Q97825082's instance of is recorded as individual motion^[3].
• Q97825082's part of the series is recorded as motions of the 2009-2010 legislative session of the Riksdag^[4].
• Q97825082's language of work or name is recorded as Swedish^[5].
• Q97825082 was published on +2009-09-29T00:00:00Z^[6].
• Q97825082's main subject is drug^[7].
• Q97825082's work available at URL is recorded as http://data.riksdagen.se/dokument/GX02So250^[8].
• Q97825082's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GX02So250^[9].
• Q97825082's applies to jurisdiction is recorded as Sweden^[10].
• Q97825082's legal citation of this text is recorded as Mot. 2009/10:So250^[11].
• Q97825082's title is recorded as Generellt tillstånd att narkotikaklassa nya preparat^[12].
• Q97825082's maintained by WikiProject is recorded as Project Riksdagen's documents^[13].
• Q97825082's copyright status is recorded as public domain^[14].
• Q97825082's legislative committee is recorded as Committee on Health and Welfare^[15].

Body

Definition and Type

Q97825082's instance of is recorded as individual motion^[3].